Clinical trial
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer
NCT03088930
Study timeline
Study start (actual)2017-12-13Date precision: day
Registry last updated2022-02-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancer, Nonsmall Cellunresolved
Interventions
CrizotinibDRUG · verified · RxNorm: crizotinib
Sponsors & collaborators
University of Colorado, Denverlead sponsor
Pfizercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03088930 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.